Teva Pharmaceutical Industries Limited · Petah Tikva Israel (Tel Aviv: TEVA)(NASDAQ: TEVA)

Teva Pharmaceutical Industries Limited Rankings

#169 in FT Global 500 (June 2011)

Company Description

The backbone of Teva Pharmaceutical Industries is its world-leading generic pharmaceuticals business. Through subsidiary Teva Pharmaceuticals USA, the company makes generic versions of hundreds of brand-name antibiotics, heart drugs, heartburn medications, and more. Teva's US generic products include equivalents of such blockbusters as antidepressant Prozac and osteoporosis drug Fosamax. The company, Israel's top drugmaker, also develops and manufactures proprietary drugs, including multiple sclerosis treatment Copaxone, Parkinson's disease treatment Azilect, and a portfolio of women's health treatments. Its active pharmaceutical ingredient (API) division makes drug components for Teva and other manufacturers.

Financials

Executives

47 executives listed for Teva Pharmaceutical Industries Limited's Petah Tikva, Israel location.

More Teva Pharmaceutical Industries Limited Executives

Top Teva Pharmaceutical Industries Limited Competitors

• Forest Laboratories, Inc.
• Johnson & Johnson
• Novartis AG